Control of MRSA skin and wound colonisation.

Dermal Laboratories0 个研究点目标入组 40 人开始时间: 2009年4月16日最近更新: 2019年1月7日

试验速览

暂无简介。

•i) Adult community patients, aged 18 years or over who are considered, by the district nurse, unlikely to be unsettled by the possibility of being invited to take part in a clinical trial involving MRSA colonisation. ii) Patients with uncomplicated venous leg ulcers (ie no clinical suspicion of microbiological infection), requiring regular nursing treatment visits, for at least 15 weeks. iii) Patients who test positive for MRSA at the perineum and/or nares.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•i) Patients with clinical signs and symptoms of infection, and therefore requiring active antimicrobial pharmacotherapy. ii) Patients with a history of intolerance or skin sensitivity to any of the ingredients of the investigational products. iii) Patients who in the opinion of the district nurse may, for whatever reason, become unduly anxious about participating in such a study involving MRSA. iv) Patients who have received any unlicensed drug within the last 30 days or who are scheduled to receive an investigative drug other than the study medications during the period of the study. v) Mentally incapacitated patients who are considered by the District Nurse as being unable to perform the 'acceptability' assessments (physically incapacitated patients with appropriate homes care may be included). vi) Patients who are pregnant or lactating (although there are no particular safety concerns in these patient groups, it is generally inappropriate for them to participate in clinical trials without overriding justification). vii) Patients with systemic diseases which, in the opinion of the investigator, may adversely influence their participation in the trial.

发起方